NeuroRx Says COVID-19 Drug Improves Survival If Overstretched ICUs Excluded

Will Seek EUA Shortly

 
• By Andrew McConaghie

Therapy shows some promise in helping COVID-19 respiratory failure patients but the US FDA may question company’s data cut. 

ICU Covid
NeuroRx argues that ICUs overwhelmed by COVID-19 cases should be excluded from the trial - but the US FDA may not agree • Source: Getty Images

More from Business

More from Scrip